| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |